Medical Affairs Seminar - Launching a High-Value Medical & Scientific Affairs Team

During the past decade, Medical Affairs has become a critical function within all pharmaceutical and biotechnology companies. A high-performance Medical Affairs team will not only support but drive the safe, effective and appropriate use of medications throughout a product lifecycle. A Medical Affairs Department is now a necessity rather than a luxury.

Launching a High Value Medical Affairs Team is an interactive learning opportunity for professionals who are setting up, expanding or restructuring Medical Affairs Departments and Groups. This program will help participants identify the needs of their organization, the appropriate structure and organizational alignment and identify critical functions, and will clarify many other operational aspects that are key to building a sustainable and respected department.

This conference will offer an opportunity to learn from others who have built Medical Affairs teams from the ground up, including the good, the bad and the ugly. Finally, and most important, the seminar is an excellent opportunity to pause from everyday duties, in order to reflect on your medical affairs strategies and tactics, and exchange experiences through networking and discussion with your peers.


“Exceptional program for mix and range of topics and speakers,”
– Paul F. Weber, MD, RPh, MBA, Executive Director, Celgene Corporation

“Yes, event met my expectations,” – Rob Naticchia, EVP, Connexion

“Yes, it was great,” – Ali Nourbakhsh, MD, Celgene Croporation

“The discussions were the best,” – Kristy Grimm, Director, Medical Affairs, Vertex Pharmaceuticals

“Establishing a formal medical affairs program for my device company, I benefitted from the cross-company discussion especially with pharma colleagues,” – Sheila Hickson-Curran, Director, Medical Affairs, J&J Vision Care

“Excellent presentation and discussion,” – Neil H. Gray, Senior VP, Medical Affairs, inVentiv Therapeutics Institute

“Thought-provoking and engaging presentation,”
Robert Garris, Associate Medical Director, Actelion Pharmaceuticals

Top Reasons to Attend

  1. Focused course learning on dynamic topic areas and burgeoning areas of importance at big and small Pharma
  2. Senior-level course leaders and guest speakers address key issues
  3. Tri-located with ExL’s 2nd Enhancing Drug Bioavailability & Solubility and
    2nd Stratified Medicine – Network with 200+ of your peers!
  4. ExL Pharma is a leader in providing industry education for Medical Affairs
  5. Centrally located in major pharma market

Who Should Attend

  • Medical Affairs/Field Medical Affairs
  • Medical Science Liaisons
  • Medical Directors/Strategy
  • Research & Development
  • Scientific Affairs
  • Medical Education
  • Investigator Initiated/Sponsored Trials
  • Clinical Research Associates
  • Post-Marketing Studies/Phase IV
  • Project Management